TREA

97003850 - REIMAGINE CARE

Follow

Information

  • Trademark
  • 97003850
  • Serial Number
    97003850
  • Registration Number
    7020321
  • Filing Date
    August 31, 2021
    3 years ago
  • Registration Date
    April 04, 2023
    a year ago
  • Transaction Date
    July 13, 2023
    a year ago
  • Status Date
    April 04, 2023
    a year ago
  • Published for Opposition Date
    August 09, 2022
    2 years ago
  • Location Date
    February 24, 2023
    2 years ago
  • First Use Anywhere Date
    August 10, 2020
    4 years ago
  • First Use In Commerce Date
    August 10, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    STIGLITZ, SUSAN R
  • Attorney Name
    Benjamin W. Janke
    Law Office Assigned Location Code
    L90
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
REIMAGINE CARE
Case File Statements
  • GS0351: Business consulting and management in the field of clinical trials, namely, providing information management services in partnership with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homes, contract clinical trials into value-based care contracts and provide clinical trial access to diverse patient populations for clinical trial participation, accelerate trial completion, and lower trial costs
  • GS0451: Providing personal support services for patients and families of patients undergoing cancer treatment, namely, emotional counseling and emotional support through volunteers in the community who include cancer survivors, as well as family members and friends of cancer patients
  • GS0441: Analysis of oncology medical information for the treatment of cancer in the home on behalf of patients and cancer care providers, including analysis of value-based care, care coordination, decision-making services, and insights, as well as the evaluation of oncology clinical research studies for patient access and participation in clinical trials; medical services in the field of oncology, namely, providing oncology infusion therapy and oral oncolytic in alternative settings; medical services, namely, providing real-time symptom management and telemedicine triage via a dedicated multi-disciplinary oncology care team to optimize adverse cancer patient events and reactions to cancer
  • GS0421: Platform as a service (PAAS) featuring computer software platforms for providing oncology hospital at home technology-enabled services in the nature of monitoring medication administration and dosage, assessing and reporting on pain levels for supporting oncologists and other healthcare providers in delivering high-quality, lower-cost, patient-centric cancer care; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer diagnosis and treatment, namely, partnering with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homes, contract clinical trials into value-based care contracts and provide clinical trial access to diverse patient populations for clinical trial participation, accelerate trial completion, and lower trial costs; Platform as a service (PAAS) featuring computer software platforms for monitoring, analyzing, assessing, transmitting patient medical and healthcare data to inform cancer care delivery optimization to patients and cancer care providers through a value-based care logistics management platform to efficiently and effectively manage workforce staffing, patient care, and pharmaceutical supplies required in alternative cancer delivery models; Platform as a service (PAAS) featuring computer software platforms for providing a comprehensive oncology clinical management solution, namely, medication administration and management, supportive care, lab testing, pain management, day-after-chemo injection of colony-stimulating factor drugs, advanced care planning, and at-home palliative care; Platform as a service (PAAS) featuring computer software platforms for providing cancer patients extensive cancer care navigation services in the nature of providing coordinated care by assessing, triaging, follow-up and supporting patients 24/7 and on-demand, for keeping patients with compromised immune function out of institutional settings and treating them in the convenience of their homes
Case File Event Statements
  • 7/12/2023 - a year ago
    26 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 4/4/2023 - a year ago
    25 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/4/2023 - a year ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/25/2023 - 2 years ago
    23 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 2/24/2023 - 2 years ago
    22 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 1/30/2023 - 2 years ago
    21 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 12/30/2022 - 2 years ago
    20 - USE AMENDMENT FILED Type: IUAF
  • 1/30/2023 - 2 years ago
    19 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/30/2022 - 2 years ago
    18 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 10/4/2022 - 2 years ago
    17 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 8/9/2022 - 2 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/9/2022 - 2 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/20/2022 - 2 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/6/2022 - 2 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/22/2022 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/22/2022 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/22/2022 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/7/2022 - 2 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/7/2022 - 2 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/7/2022 - 2 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/6/2022 - 2 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/4/2022 - 3 years ago
    5 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/4/2022 - 3 years ago
    4 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/4/2022 - 3 years ago
    3 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/14/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/3/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP